Introduction: Company Profile Randall (Xiamen) Biotechnology Co. It is a trustworthy foreign enterprise established by the United States and Canada in China. With Mr. Yang Nengliang, the executive director, as the leader, and Dr. Lin Genchun, who has been engaged in cancer research for twenty-four years, as the core of the technical group, we take a rigorous scientific attitude to give full play to the expertise of all scientific and technological personnel; and take the market as the guide to develop the world's first-class product, a cervical cancer rapid self-diagnosis reagent kit. We created this pharmaceutical and biotechnology company with the concept of saving lives, aiming at social benefits, and giving back to the society with economic benefits. However, helping every woman to get rid of the threat of cervical cancer is the ultimate goal of all our work. The company integrates scientific research, production, sales and service, and has advanced production equipment, strong technical force, high-quality staff, perfect after-sales service and management system. At the same time, for our service object is the special nature of human health, and constantly absorb both academic and capable, more serious and responsible scientific attitude of character and talent to join and enrich our technical team. Functional technology department is responsible for the research and development of new technologies and the updating and improvement of mature technologies. Functional Quality Inspection Department strictly grasps the quality of products to ensure that each batch of products are qualified. The Production Department strictly implements the program of "two checks and one sample check" to ensure that each reagent and each step are accurate. In addition to following the regular procedures, the marketing department pays special attention to inviting caring and experienced medical professionals to join us in order to do a practical good deed for the prevention and treatment of cervical cancer for women all over the world. At present, our flagship product, i.e., the Cervical Cancer Rapid Self-Testing Kit, has been approved by the State Patent Office and granted with patent rights. In order to standardize the production and ensure the quality, the relevant experts, jointly organized by Fujian Provincial Drug Administration and Quality and Technical Supervision Bureau, reviewed and unanimously approved the standard of this registered product with strict and serious scientific attitude, and at the same time, the standard test was carried out by the National Institute for Medical Device Inspection in Beijing, and all the indexes are qualified. This convenient testing method is the first of its kind in the world. The main developer is Lin Genchun, a Canadian cancer researcher introduced by the State Administration of Foreign Experts and Xiamen Personnel Bureau, who has studied in the U.S. and Canada successively, and has made outstanding achievements in the field of cancer research. He is a member of the Canadian Medical Association and a technical expert of Gemma Medical Laboratory, a member of the Chinese Society of Pathophysiology and a member of the Chinese Society of Oncology.
Legal Representative: YEUNG NELSON NANG
Foundation: 2004-10-15
Registered Capital: $500,000
Industrial and Commercial Registration No.: 350298400002283
Enterprise Type: Limited Liability Company (Foreign Joint Venture)
Address. Room 506 bis, No. 146 Canghong Road, Haicang District, Xiamen City, China